Barclays’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31K | Sell |
21,178
-40,672
| -66% | -$59.5K | ﹤0.01% | 4026 |
|
|
2025
Q1 | $86K | Sell |
61,850
-5,658
| -8% | -$7.87K | ﹤0.01% | 3741 |
|
|
2024
Q4 | $206K | Buy |
67,508
+9,441
| +16% | +$28.8K | ﹤0.01% | 3500 |
|
|
2024
Q3 | $289K | Buy |
58,067
+44,903
| +341% | +$223K | ﹤0.01% | 3305 |
|
|
2024
Q2 | $77K | Buy |
+13,164
| New | +$77K | ﹤0.01% | 3501 |
|
|
2022
Q2 | – | Sell |
-158,944
| Closed | -$445K | – | 4913 |
|
|
2022
Q1 | $445K | Buy |
+158,944
| New | +$445K | ﹤0.01% | 2878 |
|